The Glaucoma Therapeutic Market is experiencing robust expansion as the global burden of ocular disorders continues to rise, driven by an aging population and increasing prevalence of chronic conditions such as diabetes and hypertension. Glaucoma, often referred to as the "silent thief of sight," remains one of the leading causes of irreversible blindness worldwide, creating a sustained and...